CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 50 filers reported holding CORVUS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 5.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $157,715 | +8439.0% | 108,024 | -94.7% | 0.00% | -100.0% |
| Q1 2023 | $1,847 | +14.4% | 2,029,423 | +6.8% | 0.00% | 0.0% |
| Q4 2022 | $1,615 | -99.9% | 1,899,516 | -16.1% | 0.00% | 0.0% |
| Q3 2022 | $1,854,000 | -30.3% | 2,265,312 | -15.7% | 0.00% | -50.0% |
| Q2 2022 | $2,661,000 | -40.4% | 2,687,943 | -1.3% | 0.00% | 0.0% |
| Q1 2022 | $4,467,000 | -36.5% | 2,723,539 | -6.7% | 0.00% | -50.0% |
| Q4 2021 | $7,037,000 | +110.3% | 2,920,059 | +322.4% | 0.00% | +100.0% |
| Q3 2021 | $3,346,000 | +853.3% | 691,372 | +426.0% | 0.00% | – |
| Q2 2021 | $351,000 | +15.1% | 131,435 | +32.6% | 0.00% | – |
| Q1 2021 | $305,000 | -29.6% | 99,096 | -18.5% | 0.00% | – |
| Q4 2020 | $433,000 | -71.7% | 121,618 | -68.1% | 0.00% | -100.0% |
| Q3 2020 | $1,528,000 | -52.9% | 381,143 | -68.0% | 0.00% | -50.0% |
| Q2 2020 | $3,244,000 | +49.0% | 1,192,742 | +15.6% | 0.00% | -20.0% |
| Q1 2020 | $2,177,000 | -50.0% | 1,031,759 | +29.0% | 0.01% | 0.0% |
| Q4 2019 | $4,351,000 | +51.8% | 799,830 | -16.0% | 0.01% | 0.0% |
| Q3 2019 | $2,866,000 | +923.6% | 952,197 | +1174.1% | 0.01% | – |
| Q2 2019 | $280,000 | +268.4% | 74,735 | +296.9% | 0.00% | – |
| Q1 2019 | $76,000 | -65.6% | 18,830 | -68.7% | 0.00% | – |
| Q4 2018 | $221,000 | -31.2% | 60,248 | +61.2% | 0.00% | – |
| Q3 2018 | $321,000 | -91.5% | 37,370 | -89.2% | 0.00% | -100.0% |
| Q2 2018 | $3,794,000 | -45.6% | 345,574 | -42.9% | 0.01% | -44.4% |
| Q1 2018 | $6,979,000 | +1042.2% | 605,303 | +925.6% | 0.01% | +800.0% |
| Q4 2017 | $611,000 | +82.4% | 59,017 | +180.8% | 0.00% | 0.0% |
| Q3 2017 | $335,000 | -29.5% | 21,019 | -8.0% | 0.00% | 0.0% |
| Q1 2017 | $475,000 | -43.6% | 22,853 | -61.2% | 0.00% | -50.0% |
| Q4 2016 | $842,000 | -53.5% | 58,887 | -46.5% | 0.00% | -33.3% |
| Q3 2016 | $1,810,000 | +206.8% | 110,054 | +170.4% | 0.00% | +200.0% |
| Q1 2016 | $590,000 | – | 40,701 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADAMS STREET PARTNERS LLC | 3,275,616 | $28,105,000 | 4.42% |
| Novo Holdings A/S | 4,420,516 | $37,928,000 | 3.01% |
| BVF INC/IL | 1,890,507 | $16,221,000 | 1.42% |
| Orbimed Advisors | 5,967,584 | $51,202,000 | 0.62% |
| COWEN INC. | 588,706 | $5,051,000 | 0.46% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 108,000 | $710,000 | 0.34% |
| SPHERA FUNDS MANAGEMENT LTD. | 321,430 | $2,758,000 | 0.32% |
| EcoR1 Capital, LLC | 351,401 | $3,015,000 | 0.27% |
| Rock Springs Capital Management LP | 575,000 | $4,934,000 | 0.18% |
| Hikari Power Ltd | 32,090 | $275,000 | 0.03% |